NutriMind: A Combination of Healthy Diet and Psychotherapy to Treat Depression
NutriMind
The NutriMind Trial: A Low-cost Randomized Trial Combining a Healthy Diet and Psychotherapy to Treat Depressive Symptoms Among University Students - The Case of Uganda
1 other identifier
interventional
500
1 country
1
Brief Summary
University students in Low- and Middle-Income Countries (LMIC) continue to face growing rates of depression, a common mental health problem. Adding to this burden is the mental health treatment gap, necessitating the need to identify new treatment methods that can easily be implemented at a large scale. This project will test if a healthy diet combined with mindfulness-based cognitive therapy can reduce depressive symptoms among university students in Uganda, a low resource country. The burden of depression is high in sub-Saharan African countries, largely worsened by poverty, hunger and poor public health service, and lately the COVID-19 pandemic. These factors increase psychological distress among young people in sensitive periods of life, such as students who are about to choose their career and establish family. Successfully managing depression in LMIC is likely to depend on low-cost treatment that can easily be managed to large target populations, yet still be at the scientific forefront, proof-based, and culturally acceptable. This can possibly be obtained with an intervention combining healthy diet and cognitive behavioral therapy based on mindfulness principles. While healthy diets and mindfulness cognitive therapy individually can partly lessen the burden of depression, these two therapeutic modalities have not been tested in combination among university students in sub-Saharan Africa, i.e. a synergistic effect that is still to be studied. With the NutriMind Trial, its investigators focus on a neglected global mental health challenge, namely depression among university students in Uganda.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable depression
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2023
CompletedFirst Posted
Study publicly available on registry
May 8, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedMay 9, 2024
May 1, 2024
2 years
March 27, 2023
May 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline to 24 months in depressive symptoms using the Center for Epidemiological Studies - Depression (CES-D) score among the study participants randomized to each of the three intervention arms compared with the controls.
Depressive symptoms will be assessed using the CES-D score from before to after the intervention. CES-D scores range from 0 to 60, with higher scores indicating greater depressive symptoms. The CES-D provides cut-off scores (16 or greater) to aid in identifying individuals at risk for clinical depression, with good sensitivity and specificity and high internal consistency.
24 months
Secondary Outcomes (8)
Change from baseline to 24 months in depressive symptoms using the Beck Depression Inventory-II (BDI-II) score among the study participants randomized to each of the three intervention arms compared with the controls.
24 months
The health economic costs of each of the three intervention arms compared with the control group.
24 months
Change from baseline to 24 months in body weight among the study participants randomized to each of the three intervention arms compared with the controls.
24 months
Change from baseline to 24 months in body height among the study participants randomized to each of the three intervention arms compared with the controls.
24 months
Change from baseline to 24 months in body composition among the study participants randomized to each of the three intervention arms compared with the controls.
24 months
- +3 more secondary outcomes
Study Arms (4)
Healthy diet
ACTIVE COMPARATORThe study participants randomized to this arm will be given advice about consuming a healthy diet, i.e. a diet rich in vegetables/fruits and wholegrain/fibre, fish, olive oil; and moderate in red meat and dairy products. The participants will receive 8 weekly, one hour group sessions delivered by trained nutritionists.
Mindfulness-based cognitive therapy (MBCT)
ACTIVE COMPARATORThe study participants randomized to this arm will be taught the purpose and application of MBCT, namely to modify cognitive and effective processes in the management of depressive symptoms as well as relapse prevention among those with residual depressive symptoms. It is a structured 8-weeks' intervention program delivered in groups, with an all-day practice session around week six and regular reunion sessions thereafter.
Healthy diet and MBCT combined
ACTIVE COMPARATORThe study participants randomized to this arm will receive both the healthy diet intervention and the MBCT intervention
Control
NO INTERVENTIONNo particular intervention will be provided to the control group.
Interventions
The targeted study participants will be given advice about healthy dietary intakes. This will entail promotion of foods rich in vegetables/fruits and wholegrain/fibre, fish, olive oil; moderate in lean red meat and low-fat diary products). To be concrete, the study investigators will target energy (E%) from macronutrients as follows: 42 E% total fat (≥ 22 E% from monounsaturated fatty acids, 10 E% from polyunsaturated fatty acids and \<10 E% saturated fatty acids), 35 E% carbohydrate, 15 E% protein and ≤ E 5% alcohol. Importantly, this will meet all Recommended Dietary Intake requirements for adults.
MBCT is a skills-based intervention comprising a structured 8-week group intervention program to be delivered in groups of study participants, with an all-day practice session around week six and regular reunion sessions thereafter.
Eligibility Criteria
You may qualify if:
- Those who score between 16 and 25 on the CES-D scale
- Completed \>1 study-year of study and have \>2 study-years before graduation
- Not using any medication regularly that might interfere with study adherence or - outcomes
- Giving consent to participate
You may not qualify if:
- Not being diagnosed with chronic disorder or cancer
- Not being pregnant
- Not having food allergy- or intolerance
- Not having experienced recent bereavement or major personal loss (e.g. income or divorce)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bergenlead
- University of Oslocollaborator
- Makerere Universitycollaborator
Study Sites (1)
Makerere University
Kampala, Central Uganda, +26, Uganda
Related Publications (1)
Kardel KR, Iversen PO, Kaaya AN, Muhoozi G, Veierod MB, Wangen KR, Borosund E, Friberg PA. A pragmatic randomized trial to examine the effect of combining healthy diet with mindfulness cognitive therapy to reduce depressive symptoms among university students in a low-resource setting: protocol for the NutriMind Project. BMC Psychiatry. 2024 Sep 11;24(1):610. doi: 10.1186/s12888-024-06056-9.
PMID: 39261786DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prudence A Friberg
University of Bergen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The data collection teams will be blinded to the allocation arms throughout the trial in order to minimise measurement bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 27, 2023
First Posted
May 8, 2023
Study Start
January 1, 2024
Primary Completion
December 30, 2025
Study Completion
December 30, 2025
Last Updated
May 9, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- Approximately 3 years from the start of the study.When all collected data has been analysed and published the results in an open access journal.
- Access Criteria
- Project website that will be established when the study implementation starts
Informed Consent Form (ICF) will be shared with all study participants and was approved by Uganda Institutional Review Board. Clinical Study Report (CSR) will be published on the trial website that is going to be created during the study. There is signed Material Transfer Agreement (MTA) between the collaborating universities that specifies data sharing process